Hexarelin Maintains GH-Releasing Power Even After Repeated Dosing in Humans
Repeated hexarelin administration maintained its GH-releasing effect, and combining hexarelin with GHRH produced a synergistic GH response greater than either alone.
Quick Facts
What This Study Found
Hexarelin maintained GH-releasing efficacy with repeated administration, and hexarelin plus GHRH produced a synergistic GH response exceeding individual effects.
Key Numbers
How They Did This
Randomized, double-blind, crossover RCT with single IV boluses of hexarelin, GHRH, or hexarelin+GHRH administered as two sequential doses to assess responsivity maintenance.
Why This Research Matters
Tolerance is a major concern with repeated peptide use. Demonstrating that hexarelin maintains its effect with repeat dosing supports its viability as a clinical GH secretagogue.
The Bigger Picture
The synergistic effect of hexarelin plus GHRH became a key principle in growth hormone optimization — using two agents working through different receptors produces better results than maximizing either one alone.
What This Study Doesn't Tell Us
Short-term study assessing only acute repeated doses. Long-term tolerance with daily chronic use was not assessed. Sample size and specific participant numbers not detailed in abstract.
Questions This Raises
- ?Does hexarelin maintain its effectiveness over weeks or months of daily use?
- ?Is the hexarelin-GHRH synergy consistent across different patient populations and ages?
Trust & Context
- Key Stat:
- Synergistic combination effect Hexarelin plus GHRH produced a GH response greater than the sum of individual effects, confirming different mechanisms of action
- Evidence Grade:
- Strong evidence from a randomized, double-blind crossover design. Short-term acute dosing protocol limits conclusions about chronic use tolerance.
- Study Age:
- Published in 1996, this study established key principles about hexarelin dosing and GHRP-GHRH synergy that inform current peptide protocols.
- Original Title:
- The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.
- Published In:
- Clinical endocrinology, 44(5), 555-62 (1996)
- Authors:
- Massoud, A F(2), Hindmarsh, P C(2), Matthews, D R, Brook, C G
- Database ID:
- RPEP-00370
Evidence Hierarchy
Frequently Asked Questions
What is hexarelin?
Hexarelin is a synthetic six-amino-acid growth hormone-releasing peptide. It's one of the more potent GHRPs studied and works by stimulating both the pituitary and hypothalamus to release growth hormone.
Why is the synergy with GHRH important?
Hexarelin and GHRH work through completely different receptors and signaling pathways. When combined, they activate two independent GH-release mechanisms simultaneously, producing a much larger GH pulse than either alone — like pressing both the gas pedal and releasing the brake at the same time.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00370APA
Massoud, A F; Hindmarsh, P C; Matthews, D R; Brook, C G. (1996). The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.. Clinical endocrinology, 44(5), 555-62.
MLA
Massoud, A F, et al. "The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.." Clinical endocrinology, 1996.
RethinkPeptides
RethinkPeptides Research Database. "The effect of repeated administration of hexarelin, a growth..." RPEP-00370. Retrieved from https://rethinkpeptides.com/research/massoud-1996-the-effect-of-repeated
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.